Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 3rd Interim Analysis of the German Non-Interventional Trial RISA

被引：0
|
作者：
Meyer, Oliver
Stauch, Martina
Kaempfe, Dietrich
Schlag, Rudolf
Reiser, Marcel
von der Heyde, Eyck
Josting, Andreas
Plath, Margarete
Ballerstadt, Nadine
Stark-Lorenzen, Petra
Matzdorff, Axel
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Eltrombopag Plus Diacerein Versus Eltrombopag in Adult Primary Immune Thrombocytopenia: Interim Analysis of a Multicenter, Randomized, Controlled, Phase 2 Trial
    Sun, Lu
    Qin, Ping
    Xu, Ruirong
    Wang, Juandong
    Zhao, Hongyu
    Wang, Yan
    Wang, Juan
    Wang, Xin
    Hou, Yu
    Hou, Ming
    BLOOD, 2022, 140 : 8410 - 8411
  • [22] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 510 - 510
  • [23] Olaparib in German routine clinical practice - Interim results of the non-interventional study C-PATROL
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    Fasching, P. A.
    El-Balat, A.
    Glowik, R.
    Marme, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [24] OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Fasching, P. A.
    Glowik, R.
    Hilpert, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1590 - 1590
  • [25] TOCILIZUMAB, DMARDS AND GLUCOCORTICOIDS IN RHEUMATOID ARTHRITIS - INTERIM ANALYSIS OF THE GERMAN NON-INTERVENTIONAL STUDY ICHIBAN
    Specker, C.
    Kaufmann, J.
    Vollmer, M. A.
    Kellner, H.
    Hoehle, M.
    Kuehne, C.
    Volberg, C.
    Henes, J. C.
    Zinke, S.
    Moosig, F.
    Bohl-Buehler, M.
    Sieburg, M.
    Aringer, M.
    Hofmann, M. W.
    Hellmann, P.
    Fliedner, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 494 - 495
  • [26] Influence of Tocilizumab on Employment and Use of SHI Services - Interim Analysis of a German non-interventional Study
    Specker, C.
    Fliedner, G.
    Kaufholz, C.
    Hofmann, M.
    Feist, E.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 106 - 107
  • [27] Interim Analysis of Treatment Satisfaction from a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag or Romiplostim to Avatrombopag
    Tarantino, Michael D.
    Kolodny, Scott
    Zhang, Jessica
    Jamieson, Brian
    Vredenburg, Michael
    BLOOD, 2023, 142
  • [28] Four-year interim results of a non-interventional trial to assess the safety and efficacy of treatment with recombinant factor IX, BeneFIX®
    Hardewig, J.
    Oldenburg, J.
    Pollmann, H.
    HAEMOPHILIA, 2012, 18 : 24 - 24
  • [29] Median progression free survival (PFS) for patients treated with everolimus (EVE) plus exemestane (EXE) for HR plus mBC in routine clinical practice: Results of the 3rd interim analysis of the non-interventional trial BRAWO.
    Jackisch, Christian
    Fasching, Peter A.
    Grischke, Eva-Maria
    Schuetz, Florian
    Decker, Thomas
    Uleer, Christoph
    Salat, Christoph
    Foerster, Frank
    Schmidt, Marcus
    Mundhenke, Christoph
    Tesch, Hans
    Wimberger, Pauline
    Aktas, Bahriye
    Zahn, Mark-Oliver
    Tome, Oliver
    Bloch, Wilhelm
    Hanson, Sven
    Schubert, Joerg
    Lueftner, Diana
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Results of the second interim analysis of C-PATROL: A non-interventional study on olaparib within German routine clinical practice
    Marme, F.
    Hilpert, F.
    Welslau, M.
    Grabowski, J. P.
    Seitz, J.
    El-Balat, A.
    Hartkopf, A. D.
    Glowik, R.
    Sehouli, J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 250 - 251
12345